Molecular and Cellular Biochemistry

, Volume 287, Issue 1, pp 201–211

Novel Mutations that Enhance or Repress the Aggregation Potential of SOD1

Authors

  • Uma Krishnan
    • Department of NeurologyUniversity of Texas, Southwestern Medical Center
  • Marjatta Son
    • Department of NeurologyUniversity of Texas, Southwestern Medical Center
  • Bhagya Rajendran
    • Department of NeurologyUniversity of Texas, Southwestern Medical Center
    • Department of NeurologyUniversity of Texas, Southwestern Medical Center
Article

DOI: 10.1007/s11010-005-9112-4

Cite this article as:
Krishnan, U., Son, M., Rajendran, B. et al. Mol Cell Biochem (2006) 287: 201. doi:10.1007/s11010-005-9112-4

Abstract

Mutations in SOD1 cause FALS by a gain of function likely related to protein misfolding and aggregation. SOD1 mutations encompass virtually every domain of the molecule, making it difficult to identify motifs important in SOD1 aggregation. Zinc binding to SOD1 is important for structural integrity, and is hypothesized to play a role in mutant SOD1 aggregation. To address this question, we mutated the unique zinc binding sites of SOD1 and examined whether these changes would influence SOD1 aggregation. We generated single and multiple mutations in SOD1 zinc binding residues (H71, H80 and D83) either alone or in combination with an aggregate forming mutation (A4V) known to cause disease. These SOD1 mutants were assayed for their ability to form aggregates.

Using an in vitro cellular SOD1 aggregation assay, we show that combining A4V with mutations in non-zinc binding domains (G37R or G85R) increases SOD1 aggregation potential. Mutations at two zinc binding residues (H71G and D83G) also increase SOD1 aggregation potential. However, an H80G mutation at the third zinc binding residue decreases SOD1 aggregation potential even in the context of other aggregate forming SOD1 mutations. These results demonstrate that various mutations have different effects on SOD1 aggregation potential and that the H80G mutation appears to uniquely act as a dominant inhibitor of SOD1 aggregation.

Key words

aggregatesALSproteasomesuperoxide dismutasezinc

Copyright information

© Springer Science+Business Media, Inc. 2006